Literature DB >> 6581864

Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines.

G P Tuszynski, G Cossu.   

Abstract

Gossypol, a yellow pigment from the cotton plant (Gossypium) was found to have anti-tumor cell effects against several tumor cell lines grown in tissue culture. Most sensitive to the drug were melanoma and colon carcinoma cells. After 24 hr of treatment with 10 microM gossypol, over 90% of these cells were killed. A rough correlation existed between very rapidly growing cells and their sensitivity to the drug. For example, slow growing cells, such as normal embryonic lung fibroblasts and mammary adenocarcinoma, were least sensitive, requiring over 30 microM gossypol in order to kill 90% of cells after 48 hr of treatment. These results indicate that gossypol has differential cytotoxic effects against certain tumor cell types, such as melanoma and colon carcinoma, and suggest that it might be of potential therapeutic value. The drug appears to act as a metabolic poison rather than as an agent interfering with DNA synthesis at the concentrations used in the study. Cells sensitive to the drug contain the more cathodic forms of lactate dehydrogenase, lactate dehydrogenases I to III.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6581864

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

Review 1.  An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease.

Authors:  D Wu
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

Review 2.  Small-molecule inhibitors of human LDH5.

Authors:  Carlotta Granchi; Ilaria Paterni; Reshma Rani; Filippo Minutolo
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

3.  AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.

Authors:  B S Yurekli; B Karaca; A Kisim; E Bozkurt; H Atmaca; S Cetinkalp; G Ozgen; C Yilmaz; S Uzunoglu; R Uslu; F Saygili
Journal:  J Endocrinol Invest       Date:  2017-07-20       Impact factor: 4.256

4.  Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.

Authors:  Ying Wang; David M Lonard; Yang Yu; Dar-Chone Chow; Timothy G Palzkill; Bert W O'Malley
Journal:  Mol Endocrinol       Date:  2011-11-03

5.  Enhanced Neuronal Survival and Neurite Outgrowth Triggered by Novel Small Organic Compounds Mimicking the LewisX Glycan.

Authors:  Thomas Theis; Anmol Singh Johal; Maciej Kabat; Sayantani Basak; Melitta Schachner
Journal:  Mol Neurobiol       Date:  2018-03-08       Impact factor: 5.590

6.  Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cells.

Authors:  Hong Li; Longzhu Piao; Pingping Xu; Weiping Ye; Saiyi Zhong; Shu-Hong Lin; Samuel K Kulp; Yicheng Mao; Youngah Cho; L James Lee; Robert J Lee; Young C Lin
Journal:  Pharm Res       Date:  2011-06-28       Impact factor: 4.200

7.  R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells.

Authors:  Michael P Kline; S Vincent Rajkumar; Michael M Timm; Teresa K Kimlinger; Jessica L Haug; John A Lust; Philip R Greipp; Shaji Kumar
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

8.  Ionizing radiation induces myofibroblast differentiation via lactate dehydrogenase.

Authors:  J L Judge; K M Owens; S J Pollock; C F Woeller; T H Thatcher; J P Williams; R P Phipps; P J Sime; R M Kottmann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-07       Impact factor: 5.464

9.  Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123.

Authors:  C Benz; C Hollander; M Keniry; T L James; M Mitchell
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

10.  A preliminary clinical study of gossypol in advanced human cancer.

Authors:  R C Stein; A E Joseph; S A Matlin; D C Cunningham; H T Ford; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.